Suppr超能文献

相似文献

1
Nanotechnology-empowered therapeutics targeting neurodegenerative diseases.
Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2023 Sep-Oct;15(5):e1907. doi: 10.1002/wnan.1907. Epub 2023 May 30.
2
Nanotechnology-driven therapies for neurodegenerative diseases: a comprehensive review.
Ther Deliv. 2024;15(12):997-1024. doi: 10.1080/20415990.2024.2401307. Epub 2024 Sep 19.
3
Bioactive Compound-Fortified Nanocarriers in the Management of Neurodegenerative Disease: A Review.
Chem Biodivers. 2025 Jun;22(6):e202402018. doi: 10.1002/cbdv.202402018. Epub 2025 Feb 22.
4
Cell membrane-coated nanoparticles for neurodegenerative disorders management.
Int J Pharm. 2025 Aug 20;681:125875. doi: 10.1016/j.ijpharm.2025.125875. Epub 2025 Jun 20.
5
Emerging nanoparticle-based strategies to provide therapeutic benefits for stroke.
Neural Regen Res. 2025 Jun 19. doi: 10.4103/NRR.NRR-D-24-01492.
6
Nitric Oxide Therapeutics: New Hopes for More Effective Tuberculosis Treatment Combine with Targeted and Controlled Nanotechnology.
Int J Nanomedicine. 2025 Jul 19;20:9195-9218. doi: 10.2147/IJN.S531255. eCollection 2025.
7
The Application of Polymeric Nanoparticles as Drug Delivery Carriers to Cells in Neurodegenerative Diseases.
Cell Prolif. 2025 Aug;58(8):e13804. doi: 10.1111/cpr.13804. Epub 2025 Feb 11.
8
Intranasal Therapeutics for Neurodegenerative Disorders: Overcoming the Blood-Brain Barrier with Smart Formulations and Devices.
Mol Pharm. 2025 Jul 7;22(7):3602-3620. doi: 10.1021/acs.molpharmaceut.5c00386. Epub 2025 Jun 23.
10
Inorganic Nanoparticles-based Drug Delivery Systems for Neurodegenerative Diseases Therapy.
Curr Pharm Des. 2025;31(25):1998-2024. doi: 10.2174/0113816128352935250116064725.

引用本文的文献

1
Nanomaterial-enabled drug delivery systems for circadian medicine: bridging direct rhythm modulation and chronotherapy.
RSC Adv. 2025 Sep 5;15(38):31981-32008. doi: 10.1039/d5ra04137f. eCollection 2025 Aug 29.
2
Harnessing nanotechnology for stem-cell therapies: revolutionizing neurodegenerative disorder treatments - a state-of-the-art update.
Front Pharmacol. 2025 Jul 23;16:1630475. doi: 10.3389/fphar.2025.1630475. eCollection 2025.
5
(Nano)biotechnological approaches in the treatment of cervical cancer: integration of engineering and biology.
Front Immunol. 2024 Sep 13;15:1461894. doi: 10.3389/fimmu.2024.1461894. eCollection 2024.
8
Nanotechnology in the Diagnosis and Treatment of Antibiotic-Resistant Infections.
Antibiotics (Basel). 2024 Jan 25;13(2):121. doi: 10.3390/antibiotics13020121.

本文引用的文献

1
Camptothesome Potentiates PD-L1 Immune Checkpoint Blockade for Improved Metastatic Triple-Negative Breast Cancer Immunochemotherapy.
Mol Pharm. 2022 Dec 5;19(12):4665-4674. doi: 10.1021/acs.molpharmaceut.2c00701. Epub 2022 Nov 22.
2
Camptothesome elicits immunogenic cell death to boost colorectal cancer immune checkpoint blockade.
J Control Release. 2022 Sep;349:929-939. doi: 10.1016/j.jconrel.2022.07.042. Epub 2022 Aug 9.
3
Expanding RNAi therapeutics to extrahepatic tissues with lipophilic conjugates.
Nat Biotechnol. 2022 Oct;40(10):1500-1508. doi: 10.1038/s41587-022-01334-x. Epub 2022 Jun 2.
4
Applications of Phyto-Nanotechnology for the Treatment of Neurodegenerative Disorders.
Materials (Basel). 2022 Jan 21;15(3):804. doi: 10.3390/ma15030804.
5
Nanotechnology in Improving the Treatment of Huntington's Disease: a Systematic Review.
Neurotox Res. 2022 Apr;40(2):636-645. doi: 10.1007/s12640-021-00468-1. Epub 2022 Jan 21.
7
Cholesterol-functionalized DNA/RNA heteroduplexes cross the blood-brain barrier and knock down genes in the rodent CNS.
Nat Biotechnol. 2021 Dec;39(12):1529-1536. doi: 10.1038/s41587-021-00972-x. Epub 2021 Aug 12.
9
An Appropriate Use of Accelerated Approval - Aducanumab for Alzheimer's Disease.
N Engl J Med. 2021 Aug 26;385(9):856-857. doi: 10.1056/NEJMc2111960. Epub 2021 Jul 28.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验